Editas Medicine, Inc.
EDIT
$2.35
-$0.11-4.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.62M | -25.12M | -53.24M | -76.09M | -45.40M |
| Total Depreciation and Amortization | 805.00K | 721.00K | 1.83M | 1.92M | 3.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 4.57M | 5.81M | 8.76M | 3.56M |
| Change in Net Operating Assets | -33.21M | -11.01M | -4.62M | 17.62M | -12.10M |
| Cash from Operations | -36.39M | -30.84M | -50.21M | -47.80M | -50.76M |
| Capital Expenditure | -60.00K | -433.00K | 0.00 | -114.00K | -540.00K |
| Sale of Property, Plant, and Equipment | 118.00K | 0.00 | 151.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 40.01M | 42.50M | 56.50M | 31.50M |
| Cash from Investing | 58.00K | 39.57M | 42.65M | 56.39M | 30.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.33M | 17.17M | 7.41M | 1.44M | 269.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -2.87M | 55.24M |
| Cash from Financing | 17.33M | 17.17M | 7.41M | -1.44M | 55.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.00M | 25.90M | -150.00K | 7.15M | 35.71M |